Save time and get answers to complex questions with AI chat
Dabrafenib btd date 2023?Tenofovir generic patent?The expiration date of the key patent for guselkumab?Brenzavvy discontinuation?Zemdri nce gain exclusivity 2028 patent 2031?
See the DrugPatentWatch profile for Skyrizi
For Skyrizi (risankizumab-rzaa), the typical “starter” (induction) dosing schedule is based on the condition being treated:
After completing the initial injections (Week 0 and Week 4), maintenance dosing generally continues at: - 150 mg every 12 weeks for plaque psoriasis [1]
Skyrizi dosing depends on the specific diagnosis and indication (the “starter dose” schedule is not automatically the same across all uses). If you tell me which condition you’re asking about (plaque psoriasis, psoriatic arthritis, Crohn’s, etc.), I can map the exact induction schedule for that indication using the provided label information [1].
The starter dose refers to the fixed amount of medication per injection: - 150 mg per subcutaneous injection [1] If you share whether you’re using the prefilled pen or prefilled syringe (and your country), I can help you interpret the dosing instructions that match that device.
[1] https://www.drugs.com/skyrizi.html
Other Questions About Skyrizi :